Lung carcinoma signaling pathways activated by smoking

Chinese Journal of Cancer

Volumn 30, Issue 8, 2011, Pages 551-558

  Wen, Jing ^a,b,c   Fu, Jian Hua ^b,c   Zhang, Wei ^a   Guo, Ming ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b State Key Laboratory of Oncology   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Carcinogenesis; Cigarette smoking; Lung cancer; Signaling pathways

Indexed keywords

4 AMINOBUTYRIC ACID; BETA ADRENERGIC RECEPTOR; CARCINOGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINIC RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN; TOBACCO SMOKE;

APOPTOSIS; CANCER INVASION; CANCER RISK; CELL PROLIFERATION; CHRONIC INFLAMMATION; CIGARETTE SMOKING; GENE OVEREXPRESSION; HUMAN; INTRACELLULAR SIGNALING; LUNG CARCINOGENESIS; LUNG CARCINOMA; MEDIATOR RELEASE; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SMOKING; TRANSCRIPTION INITIATION; TUMOR GROWTH;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; GAMMA-AMINOBUTYRIC ACID; HUMANS; LUNG NEOPLASMS; NF-KAPPA B; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA; SMOKING;

EID: 80051763562     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.011.10059     Document Type: Review

References (74)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007 [J]. CA Cancer J Clin, 2007,57(1):43-66.
2. Alberg AJ, Ford JG, Samet JM, et al. Epidemiology of lung cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd edition) [J]. Chest, 2007,132(3 Suppl):29S-55S.
3. Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours [J]. Eur Respir J, 2001,18(6):1059-1068.
4. Herbst RS, Heymach JV, Lippman SM. Lung cancer [J]. N Engl J Med, 2008,359(13): 1367-1380.
5. Thun MJ, Lally CA, Flannery JT, et al. Cigarette smoking and changes in the histopathology of lung cancer [J]. J Natl Cancer Inst, 1997,89(21):1580-1586.
6. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease [J]. Nat Rev Cancer, 2007,7(10):778-790.
7. Schuller HM, Tithof PK, Williams M, et al. The tobacco-specific carcinogen 4-(methylnitrosamino)-1- (3 -py ridyl)-1- butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid [J]. Cancer Res, 1999,59(18):4510-4515.
8. Barnes PJ. Beta-adrenergic receptors and their regulation [J]. Am J Respir Crit Care Med, 1995,152(3):838-860.
9. Schuller HM. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development [J]. Nat Rev Cancer, 2002,2(6):455-463.
10. El-Bayoumy K, Iatropoulos M, Amin S, et al. Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4- (3 -pyridyl)-1- butanone: the impact of a high-fat diet [J]. Cancer Res, 1999,59(7):1400-1403.
11. Castonguay A, Rioux N, Duperron C, et al. Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis [J]. Exp Lung Res, 1998,24(4):605-615.
12. Laag E, Majidi M, Cekanova M, et al. NNK activates ERK1/2 and CREB/ATF-1 via beta-1- A R and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells [J]. Int J Cancer, 2006,119(7):1547-1552.
13. Schuller HM, Cekanova M. NNK-induced hamster lung adenocarcinomas over-ex press beta2-adrenergic and EGFR signaling pathways [J]. Lung Cancer, 2005,49(1):35-45.
14. Cekanova M, Majidy M, Masi T, et al. Overexpressed Raf-1 and phosphorylated cyclic adenosine 3'-5' -monophosphatate response element-binding protein are early markers for lung adenocarcinoma [J]. Cancer, 2007,109(6):1164-1173.
15. Sakamoto KM, Frank DA. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy [J]. Clin Cancer Res, 2009,15(8):2583-2587.
16. Aggarwal S, Kim SW, Ryu SH, et al. Growth suppression of lung cancer cells by targeting cyclic Amp response element-binding protein [J]. Cancer Res, 2008,68(4):981-988.
17. Seo HS, Liu DD, Bekele BN, et al. Cyclic Amp response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer [J]. Cancer Res, 2008,68(15):6065-6073.
18. Jin Z, Gao F, Flagg T, et al. Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis [J]. J Biol Chem, 2004,279(22):23837-23844.
19. Portugal GS, Gould TJ. Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: Converging evidence from human and animal research [J]. Behav Brain Res, 2008,193(1):1-16.
20. Schuller HM. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? [J]. Nat Rev Cancer, 2009,9 (3):195-205.
21. Wang Y, Pereira EF, Maus AD, et al. Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors [J]. Mol Pharmacol, 2001,60(6):1201-1209.
22. Plummer HK, 3rd, Dhar M, Schuller HM. Expression of the alpha7 nicotinic acetylcholine receptor in human lung cells [J]. Respir Res, 2005,6:29.
23. Zheng Y, Ritzenthaler JD, Roman J, et al. Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression [J]. Am J Respir Cell Mol Biol, 2007,37(6):681-690.
24. Song P, Sekhon HS, Fu XW, et al. Activated cholinergic signaling provides a target in squamous cell lung carcinoma [J]. Cancer Res, 2008,68(12):4693-4700.
25. Codignola A, Tarroni P, Cattaneo MG, et al. Serotonin release and cell proliferation are under the control of alpha-bungarotoxin-se nsitive nicotinic receptors in small-cell lung carcinoma cell lines [J]. FEBS Lett, 1994,342(3):286-290.
26. Schuller HM. Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways [J]. Neurotoxicology, 1994,15(4):877-886.
27. Schuller HM, Orloff M. Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells [J]. Biochem Pharmacol, 1998,55(9): 1377-1384.
28. Sciamanna MA, Griesmann GE, Williams CL, et al. Nicotinic acetylcholine receptors of muscle and neuronal (alpha7) types coexpressed in a small cell lung carcinoma [J]. J Neurochem, 1997,69(6):2302-2311.
29. Schuller HM, Jull BA, Sheppard BJ, et al. Interaction of tobacco-specific toxicants with the neuronal alpha (7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders [J]. Eur J Pharmacol, 2000,393(1-3): 265-277.
30. Jull BA, Plummer HK, 3rd, Schuller HM. Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/ MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells [J]. J Cancer Res Clin Oncol, 2001,127 (12):707-717.
31. Jin Z, Gao F, Flagg T, et al. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1- (3-py ridyl)-1- bu tanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation [J]. J Biol Chem, 2004,279(38):40209-40219.
32. West KA, Brognard J, Clark AS, et al. Rapid akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells [J]. J Clin Invest, 2003,111(1):81-90.
33. Dasgupta P, Kinkade R, Joshi B, et al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin [J]. Proc Natl Acad Sci U S A, 2006,103 (16):6332-6337.
34. Heusch WL, Maneckjee R. Signaling pathways involved in nicotine regulation of apoptosis of human lung cancer cells [J]. Carcinogenesis, 1998,19(4):551-556.
35. Dasgupta P, Rastogi S, Pillai S, et al. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-R af-1 pathways [J]. J Clin Invest, 2006,116(8):2208-2217.
36. Zhong CY, Zhou YM, Douglas GC, et al. MAPK/AP-1 signal pathway in tobacco smoke-in duced cell proliferation and squamous metaplasia in the lungs of rats [J]. Carcinogenesis, 2005,26(12):2187-2195.
37. Zhang J, Kamdar O, Le W, et al. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer [J]. Am J Respir Cell Mol Biol, 2009,40(2):135-146.
38. Chu M, Guo J, Chen CY. Long-term exposure to nicotine, via ras pathway, induces cyclin D1 to stimulate G 1 cell cycle transition [J]. J Biol Chem, 2005,280(8):6369-6379.
39. Tsai JR, Chong IW, Chen CC, et al. Mitogen-activated protein kinase pathway was significantly activated in human bronchial epithelial cells by nicotine [J]. DNA Cell Biol, 2006,25(5):312-322.
40. Zhang Q, Tang X, Zhang ZF, et al. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways [J]. Clin Cancer Res, 2007,13(16):4686-4694.
41. Hung YH, Hung WC. 4-(Methylnitrosamino)-1- (3 -py ridyl)-1-butanone (NNK) enhances invasiveness of lung cancer cells by up-regulating contactin-1 via the alpha7 nicotinic acetylcholine receptor/ERK signaling pathway [J]. Chem Biol Interact, 2009,179(2-3):154-159.
42. Mai H, May WS, Gao F, et al. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis [J]. J Biol Chem, 2003,278(3):1886-1891.
43. Paleari L, Catassi A, Ciarlo M, et al. Role of alpha7-ni cotinic acetylcholine receptor in human non-sm all cell lung cancer proliferation [J]. Cell Prolif, 2008,41(6):936-959.
44. Xu L, Deng X. Tobacco-specific nitrosamine 4- (methylnitrosamino)-1- (3 -py ridyl)-1- butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion [J]. J Biol Chem, 2004,279(51):53683-53690.
45. Xu L, Deng X. Protein kinase ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains [J]. J Biol Chem, 2006,281(7):4457-4466.
46. Volm M, Koomagi R. Association of cyclin D1 expression in lung cancer and the smoking habits of patients [J]. Cancer Lett, 1999,141(1-2):147-150.
47. Ratschiller D, Heighway J, Gugger M, et al. Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival [J]. J Clin Oncol, 2003,21(11):2085-2093.
48. Schuller HM, Witschi HP, Nylen E, et al. Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1- (3 -pyridyl)-1- butanone and the modulating effect of hyperoxia [J]. Cancer Res, 1990,50(6):1960-1965.
49. Schuller HM, McGavin MD, Orloff M, et al. Simultaneous exposure to nicotine and hyperoxia causes tumors in hamsters [J]. Lab Invest, 1995,73(3):448-456.
50. Gwilt CR, Donnelly LE, Rogers DF. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? [J]. Pharmacol Ther, 2007,115 (2):208-222.
51. Kuo WH, Chen JH, Lin HH, et al. Induction of apoptosis in the lung tissue from rats exposed to cigarette smoke involves p38/ JNK MAPK pathway [J]. Chem Biol Interact, 2005,155(1-2): 31-42.
52. Mountzios G, Planchard D, Besse B, et al. Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers [J]. Clin Cancer Res, 2008,14(13):4096-4102.
53. Greenberg AK, Basu S, Hu J, et al. Selective p38 activation in human non-small cell lung cancer [J]. Am J Respir Cell Mol Biol, 2002,26(5):558-564.
54. Tsurutani J, Castillo SS, Brognard J, et al. Tobacco components stimulate akt-dependent proliferation and nfkappab-dependent survival in lung cancer cells [J]. Carcinogenesis, 2005,26(7):1182-1195.
55. West KA, Linnoila IR, Belinsky SA, et al. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-ki nase/Akt pathway in vitro and in vivo [J]. Cancer Res, 2004,64(2):446-451.
56. Xin M, Deng X. Nicotine inactivation of the proapoptotic function of bax through phosphorylation [J]. J Biol Chem, 2005,280(11):10781-10789.
57. Paleari L, Sessa F, Catassi A, et al. Inhibition of non-neuronal alpha7-ni cotinic receptor reduces tumorigenicity in A549 NSCLC xenografts [J]. Int J Cancer, 2009,125(1):199-211.
58. Lim WT, Zhang WH, Miller CR, et al. PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer [J]. Oncol Rep, 2007,17 (4):853-857.
59. Dutu T, Michiels S, Fouret P, et al. Differential expression of biomarkers in lung adenocarcinoma: A comparative study between smokers and never-sm okers [J]. Ann Oncol, 2005,16 (12):1906-1914.
60. Ho YS, Chen CH, Wang YJ, et al. Tobacco-specific carcinogen 4-(methylnitrosamino)-1- (3 -pyridyl)-1- butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation [J]. Toxicol Appl Pharmacol, 2005,205(2):133-148.
61. Zhao J, Harper R, Barchowsky A, et al. Identification of multiple MAPK-mediated transcription factors regulated by tobacco smoke in airway epithelial cells [J]. Am J Physiol Lung Cell Mol Physiol, 2007,293(2):L480-L490.
62. Anto RJ, Mukhopadhyay A, Shishodia S, et al. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB (alpha): correlation with induction of cyclooxygenase-2 [J]. Carcinogenesis, 2002,23(9):1511-1518.
63. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases [J]. N Engl J Med, 1997,336(15):1066-1071.
64. Shishodia S, Potdar P, Gairola CG, et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-ka ppaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 [J]. Carcinogenesis, 2003,24(7): 1269-1279.
65. Shishodia S, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-ka ppaB by suppressing activation of ikappabalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9 [J]. Cancer Res, 2004,64(14):5004-5012.
66. Li MY, Yip J, Hsin MK, et al. Haem oxygenase-1 plays a central role in NNK-m ediated lung carcinogenesis [J]. Eur Respir J, 2008,32(4):911-923.
67. Martey CA, Pollock SJ, Turner CK, et al. Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: Implications for lung inflammation and cancer [J]. Am J Physiol Lung Cell Mol Physiol, 2004,287(5):L981-L991.
68. Nishikawa M, Kakemizu N, Ito T, et al. Superoxide mediates cigarette smoke-in duced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo [J]. Am J Respir Cell Mol Biol, 1999,20(2):189-198.
69. Yang SR, Valvo S, Yao H, et al. IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung [J]. Am J Respir Cell Mol Biol, 2008,38(6):689-698.
70. Rodriguez-Roisin R, Soriano JB. Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease [J]. Proc Am Thorac Soc, 2008,5(8):842-847.
71. Richter A, O'Donnell RA, Powell RM, et al. Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke [J]. Am J Respir Cell Mol Biol, 2002,27(1):85-90.
72. Lemjabbar H, Li D, Gallup M, et al. Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin [J]. J Biol Chem, 2003,278(28):26202-26207.
73. Shao MX, Nakanaga T, Nadel JA. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-al pha-converting enzyme in human airway epithelial (NCI-H292) cells [J]. Am J Physiol Lung Cell Mol Physiol, 2004,287(2):L420 -L427.
74. Schuller HM, Al-Wadei HA, Majidi M. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma [J]. Carcinogenesis, 2008,29(10):1979 -1985.